Envoy Medical (COCH) Cash & Current Investments (2020 - 2026)

Envoy Medical has disclosed Cash & Current Investments across 7 years of filings, most recently posting $19.7 million for Q2 2026.

• In Q2 2026, Cash & Current Investments rose 272.21% year-over-year to $19.7 million; the TTM figure through Jun 2026 stood at $19.7 million (up 272.21% YoY), while the FY2025 annual figure was $3.7 million, down 31.81% from the prior year.
• Cash & Current Investments came in at $19.7 million for Q2 2026 at Envoy Medical, down from $25.3 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $25.3 million in Q1 2026 to a low of $68000.0 in Q2 2023.
• Average Cash & Current Investments over 5 years is $6.0 million, with a median of $4.0 million recorded in 2023.
• Year-over-year, Cash & Current Investments sank 94.1% in 2022 and surged 7264.31% in 2023.
• Over 5 years, Cash & Current Investments stood at $183000.0 in 2022, then surged by 2205.46% to $4.2 million in 2023, then grew by 29.96% to $5.5 million in 2024, then tumbled by 31.81% to $3.7 million in 2025, then jumped by 426.32% to $19.7 million in 2026.
• Per Business Quant data, the three most recent Cash & Current Investments figures were $19.7 million in Q2 2026, $25.3 million in Q1 2026, and $3.7 million in Q4 2025.